JOHNSON AND JOHNSON: Re-accumulation is targeting $175.JNJ is neutral on its 1D technical outlook (RSI = 49.991, MACD = -1.040, ADX = 18.184) as it's only trading around its 1W MA50 but having made an impressive rebound 4 weeks ago inside the Demand Zone. This is the 4th time this Demand Zone provided a rally and the last one even crossed over the 3 yea
Key stats
About Johnson & Johnson
Sector
Industry
CEO
Joaquin Duato
Website
Headquarters
New Brunswick
Founded
1887
ISIN
ARDEUT112687
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
JNJ - 2 scenariosHi traders,
JNJ is currently consolidating inside a symmetrical triangle.
We can expect two scenarios:
Bullish scenario:
Open a long position if the price breaks the downsloping resistance line.
SL: below $153.50
Potential TP: $164
Bearish scenario:
Open a short position if the price breaks down a
Buy JNJ for Stable Gains Amid Earnings Optimism Next Week
- Key Insights: Johnson & Johnson demonstrated robust earnings performance with
an EPS of $2.77, surpassing consensus estimates and reinforcing its
defensive stock status. Its diverse portfolio and consistent ability to
execute in volatile markets make it a strong candidate for growth-oriente
Johnson & Johnson Wave Analysis – 18 April 2025
- Johnson & Johnson rising inside weekly price range
- Likely to test resistance level 165.60
Johnson & Johnson continues to rise in the primary upward impulse wave 3, which started earlier from the major support level 145.00 (lower border of the weekly sideways price range from 2023).
The up
Johnson & Johnson Beats Q1 Estimates, Premarket Not Doing WellJohnson & Johnson (NYSE: NYSE:JNJ ) on Tuesday reported better-than-expected Q1 results and lifted its sales forecast for the full year.
Johnson & Johnson (NYSE: NYSE:JNJ ), together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the h
Johnson & Johnson (JNJ) Shares Drop Over 7%Johnson & Johnson (JNJ) Shares Drop Over 7%
As the chart shows, Johnson & Johnson (JNJ) shares declined by approximately 7.6%, reaching their lowest level since late February. This marked one of the worst performances in the stock market yesterday.
Why Did JNJ Shares Fall?
Two major bearish fac
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US478160CS1
JOHNSON&JOHN 20/50Yield to maturity
7.03%
Maturity date
Sep 1, 2050
US478160CT9
JOHNSON&JOHN 20/60Yield to maturity
6.95%
Maturity date
Sep 1, 2060
US478160CR3
JOHNSON&JOHN 20/40Yield to maturity
6.45%
Maturity date
Sep 1, 2040
US478160CM4
JOHNSON & JOHNSON 17/48Yield to maturity
6.22%
Maturity date
Jan 15, 2048
JNJJ
JOHNSON & JOHNSON 17/47Yield to maturity
6.07%
Maturity date
Mar 3, 2047
US478160BV5
JOHNSON & JOHNSON 16/46Yield to maturity
6.04%
Maturity date
Mar 1, 2046
US478160CL6
JOHNSON & JOHNSON 17/38Yield to maturity
5.58%
Maturity date
Jan 15, 2038
US478160CX0
JOHNSON&JOHN 24/54Yield to maturity
5.56%
Maturity date
Jun 1, 2054
JNJ4077469
Johnson & Johnson 4.5% 05-DEC-2043Yield to maturity
5.49%
Maturity date
Dec 5, 2043
JNJ.GT
Johnson & Johnson 4.5% 01-SEP-2040Yield to maturity
5.40%
Maturity date
Sep 1, 2040
US478160CF9
JOHNSON & JOHNSON 17/37Yield to maturity
5.37%
Maturity date
Mar 3, 2037
See all DJNJ3 bonds
Curated watchlists where DJNJ3 is featured.